Cargando…
Mineral and bone disorders in chronic kidney disease and end-stage renal disease patients: new insights into vitamin D receptor activation
Progressive loss of kidney function leads to reduced production of calcitriol (1,25-dihydroxyvitamin D; active vitamin D) and an imbalance in serum calcium (Ca) and phosphorus (P) levels, which are associated with progression of renal failure as well as increased rates of cardiovascular (CV) events...
Autores principales: | Bover, Jordi, Cozzolino, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089613/ https://www.ncbi.nlm.nih.gov/pubmed/25018911 http://dx.doi.org/10.1038/kisup.2011.28 |
Ejemplares similares
-
Evidence in chronic kidney disease–mineral and bone disorder guidelines: is it time to treat or time to wait?
por: Bover, Jordi, et al.
Publicado: (2020) -
Which Outcome in Chronic Kidney Disease-Mineral and Bone Disorder Patients?
por: Cozzolino, Mario
Publicado: (2014) -
Vitamin D and Chronic Kidney Disease Association with Mineral and Bone Disorder: An Appraisal of Tangled Guidelines
por: Bover, Jordi, et al.
Publicado: (2023) -
Small steps towards the potential of ‘preventive’ treatment of early phosphate loading in chronic kidney disease patients
por: Bover, Jordi, et al.
Publicado: (2019) -
Current and Emerging Markers and Tools Used in the Diagnosis and Management of Chronic Kidney Disease–Mineral and Bone Disorder in Non-Dialysis Adult Patients
por: Fusaro, Maria, et al.
Publicado: (2023)